Similar Articles
231 Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma
232 Cell division cyclin 25C knockdown inhibits hepatocellular carcinoma development by inducing endoplasmic reticulum stress
233 Coexistence of liver abscess, hepatic cystic echinococcosis and hepatocellular carcinoma: A case report
234 Albumin–bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia
235 Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome
236 Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion
237 Multidisciplinary comprehensive treatment of massive hepatocellular carcinoma with hemorrhage: A case report and review of literature
238 Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study
239 Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo
240 Application of artificial intelligence in the prediction of immunotherapy efficacy in hepatocellular carcinoma: Current status and prospects
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA